A study of Barrett’s adenocarcinoma indicated that the gene expression of GSTM2, GSTM3 and GSTM5, but not GSTM4, was lower in tumors than in normal tissues and that DNA methylation also regulates gene expression [23]. The gene discussed is GSTM5; the disease is Barrett adenocarcinoma.